Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
Sales | 2,338,000 | 2,331,000 | 2,333,000 | 2,486,000 | 2,453,000 |
Cost of Goods | 1,546,000 | 1,560,000 | 1,575,000 | 1,618,000 | 1,611,000 |
Gross Profit | 792,000 | 771,000 | 758,000 | 868,000 | 842,000 |
Operating Expenses | 444,000 | 466,000 | 623,000 | 476,000 | 454,000 |
Operating Income | 348,000 | 305,000 | 135,000 | 392,000 | 388,000 |
Interest Expense | 37,000 | 35,000 | 32,000 | 33,000 | 36,000 |
Other Income | 13,000 | 12,000 | 9,000 | -2,000 | -25,000 |
Pre-tax Income | 324,000 | 282,000 | 112,000 | 357,000 | 327,000 |
Income Tax | 75,000 | 65,000 | -4,000 | 81,000 | 77,000 |
Net Income Continuous | 249,000 | 217,000 | 116,000 | 276,000 | 250,000 |
Minority Interests | 14,000 | 15,000 | 15,000 | 20,000 | 16,000 |
Net Income | $235,000 | $202,000 | $101,000 | $256,000 | $234,000 |
EPS Basic Total Ops | 2.08 | 1.80 | 0.93 | 2.20 | 2.00 |
EPS Basic Continuous Ops | 2.22 | 1.94 | 1.10 | 2.38 | 2.14 |
EPS Diluted Total Ops | 2.05 | 1.78 | 0.92 | 2.17 | 1.96 |
EPS Diluted Continuous Ops | 2.18 | 1.92 | 1.08 | 2.34 | 2.10 |
EPS Diluted Before Non-Recurring Items | 2.30 | 2.04 | 1.98 | N/A | N/A |
EBITDA(a) | $460,000 | $412,000 | $251,000 | $500,000 | $495,000 |